These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7104220)

  • 21. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 22. High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
    Besner JG; Meloche S; Leclaire R; Band P; Mailhot S
    J Chromatogr; 1982 Sep; 231(2):467-72. PubMed ID: 6215418
    [No Abstract]   [Full Text] [Related]  

  • 23. Etretinate therapy improves psoriasis but elevates serum lipids.
    Cowart VS
    JAMA; 1982 May; 247(19):2647-8. PubMed ID: 7077753
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of mycosis fungoides with tumoral manifestations, treated with RO 10-9359 (Tigáson)].
    Ippolito F; Giacalone B
    Ann Dermatol Venereol; 1982; 109(1):65-72. PubMed ID: 7073187
    [No Abstract]   [Full Text] [Related]  

  • 25. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
    De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
    J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etretinat (Tigason). A vitamin A acid derivative for peroral treatment of hyperkeratotic dermatoses].
    Foged EK; Laurberg G; Schmidt H
    Ugeskr Laeger; 1983 Jun; 145(23):1797-9. PubMed ID: 6879814
    [No Abstract]   [Full Text] [Related]  

  • 27. Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier's disease.
    Kramer M
    Acta Derm Venereol; 1982; 62(3):267-8. PubMed ID: 6179378
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etretinate in treatment of actinic keratosis. A double-blind crossover study.
    Moriarty M; Dunn J; Darragh A; Lambe R; Brick I
    Lancet; 1982 Feb; 1(8268):364-5. PubMed ID: 6120350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor action of retinoids: inhibition of tumor cell line-induced angiogenesis and prevention of tumors in mice.
    Szmurlo A; Marczak M; Jablonska S; Bollag W
    Dermatology; 1992; 184(2):116-9. PubMed ID: 1379857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiments on the influence of an aromatic retinoid on the chemical carcinogenesis induced by N-nitroso-methyl benzylamine in rats.
    Schmähl D; Habs M
    Arzneimittelforschung; 1981; 31(4):677-9. PubMed ID: 7195715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the use of Ro 10-9359 (Tigason) in children justified?
    van der Rhee HJ; van Gelderen HH; Polano MK
    Acta Derm Venereol; 1980; 60(3):274-5. PubMed ID: 6158237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man.
    Michaëlsson G; Bergqvist A; Vahlquist A; Vessby B
    Br J Dermatol; 1981 Aug; 105(2):201-5. PubMed ID: 7284249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dyskeratosis follicularis vegetans (Darier disease)--therapy with the aromatic retinoid RO 10-9359 (Tigason) in combination with systemic photochemotherapy (RePUVA)].
    Sönnichsen N; Brenke A; Diezel W
    Dermatol Monatsschr; 1982 Aug; 168(8):520-2. PubMed ID: 7173474
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effect of retinoid (RO 10-9359) on chemotaxis and random migration of polymorphonuclear leucocytes in patients with pustulosis palmaris et plantaris].
    Aso K; Amano N
    Nihon Hifuka Gakkai Zasshi; 1983 Feb; 93(3):333-7. PubMed ID: 6348350
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of phorbol myristate acetate and phytohemagglutinin stimulation of human lymphocytes by 13-cis-retinoic acid and ethyl etrinoate.
    Skinnider LF; Giesbrecht K
    Experientia; 1981 Dec; 37(12):1345-6. PubMed ID: 6948686
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etretinate (Tigason). A drug for skin diseases with disturbances in keratinization].
    Langeland J; Mørk NJ
    Tidsskr Nor Laegeforen; 1982 Oct; 102(30):1579-80. PubMed ID: 6188237
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention and reversal by a retinoid of 3,4-benzpyrene- and cigarette smoke condensate-induced hyperplasia and metaplasia of rodent respiratory epithelia in organ culture.
    Lasnitzki I; Bollag W
    Cancer Treat Rep; 1982 Jun; 66(6):1375-80. PubMed ID: 6282456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.